A comparative analysis of HAS-BLED, ORBIT, DOAC, and AF-BLEED bleeding-risk scores in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia atrial fibrillation project III (MAFP-III) cohort
Journal of Thrombosis and Haemostasis · 2026-02 · 24 (2) · 431-442
DOI: 10.1016/j.jtha.2025.07.040 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-02. Verfasst von Eva Soler-Espejo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitari…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Hemorrhage, Decision Support Techniques. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España, European Regional Development Fund, Fundación Séneca.
Abstract (Originalsprache)
BACKGROUND: Patients with atrial fibrillation (AF) often require oral anticoagulation (OAC), but predicting bleeding risk remains challenging. Classic risk scores such as HAS-BLED and ORBIT, along with newer models such as DOAC and AF-BLEED, exhibit only modest predictive performance. OBJECTIVES: In this study, we compared these 4 scores in patients with AF on OAC to evaluate their predictive accuracy and clinical utility. METHODS: We included patients with AF starting OAC between January 2016 and November 2021. Endpoints assessed were major bleeding, major bleeding/clinically relevant nonmajor bleeding (CRNMB), and intracranial hemorrhage (ICH). Score performance was assessed through discrimination, calibration, reclassification (net reclassification improvement), decision curve analysis, and accuracy over a 2-year follow-up period. RESULTS: In total, 3259 patients with AF were included (median age, 77 years; IQR, 70-83 years; 52.8% female). Over 2 years' follow-up, 196 patients (6.35%/year) experienced major bleeding, 413 (10.3%/year) major bleeding/CRNMB, and 32 (0.5%/year) experienced ICH. All risk scores performed modestly for major bleeding (c-indexes,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain; Liverpool Centre of Cardiovascular S…
- Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.
- Liverpool Centre of Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK; Faculty of Nursing, University of Murcia, Murcia, Spain. Ele…
- Professional Development Unit, Servicio Murciano de Salud, Murcia, Spain.
- Department of Hematology, Hospital Clínico Universitario Virgen de la Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain. Electronic address: https://x.com/vr…
- Liverpool Centre of Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, UK; Department of Clinical Medicine, Aalborg University, Aalborg…
Förderung
- Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España
- European Regional Development Fund
- Fundación Séneca
- European Social Fund Plus
- Carlos III Health Institute
Zitieren
APA
Soler-Espejo, E., Ramos-Bratos, M. P., Rivera-Caravaca, J. M., González-Lozano, E., Marín, F., Roldán, V., & Lip, G. Y. H. (2026). A comparative analysis of HAS-BLED, ORBIT, DOAC, and AF-BLEED bleeding-risk scores in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia atrial fibrillation project III (MAFP-III) cohort. Journal of Thrombosis and Haemostasis, 24(2), 431-442. https://doi.org/10.1016/j.jtha.2025.07.040
Vancouver
Soler-Espejo E, Ramos-Bratos MP, Rivera-Caravaca JM, González-Lozano E, Marín F, Roldán V, et al. A comparative analysis of HAS-BLED, ORBIT, DOAC, and AF-BLEED bleeding-risk scores in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia atrial fibrillation project III (MAFP-III) cohort. Journal of Thrombosis and Haemostasis. 2026;24(2):431-442. doi:10.1016/j.jtha.2025.07.040
BibTeX
@article{SolerEspejo2026,
author = {Soler-Espejo, Eva and Ramos-Bratos, María Pilar and Rivera-Caravaca, José Miguel and González-Lozano, Eduardo and Marín, Francisco and Roldán, Vanessa and Lip, Gregory Y H},
title = {A comparative analysis of HAS-BLED, ORBIT, DOAC, and AF-BLEED bleeding-risk scores in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia atrial fibrillation project III (MAFP-III) cohort},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
volume = {24},
number = {2},
pages = {431--442},
doi = {10.1016/j.jtha.2025.07.040}
}
EUVIMED